Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01F MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
J01FA Macrolides
J01FA15 Telithromycin
D01078 Telithromycin (JAN/USAN/INN)
Drug groups [BR:br08330]
Antibacterial
DG01551 Macrolide antibiotic
D01078 Telithromycin
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
D01078 Telithromycin
DG01633 CYP3A/CYP3A4 substrate
D01078 Telithromycin
Metabolizing enzyme inhibitor
DG01645 CYP2D6 inhibitor
D01078 Telithromycin
DG02852 CYP3A/CYP3A4 inhibitor
D01078 Telithromycin
Antimicrobials [BR:br08307]
Antibacterials
Protein biosynthesis inhibitor
Macrolide
D01078 Telithromycin (JAN/USAN/INN)
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Protein biosynthesis inhibitor
Macrolide
D01078 Telithromycin (JAN/USAN/INN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D01078
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D01078
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D01078
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01078
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D01078